Atrial flow regulator for drug-resistant pulmonary hypertension in a young child

Ellen Vanhie; Kristof VandeKerckhove; Nikolaus A Haas; Daniel De Wolf

doi:10.1002/ccd.29590

Atrial flow regulator for drug-resistant pulmonary hypertension in a young child

Catheter Cardiovasc Interv. 2021 May 1;97(6):E830-E834. doi: 10.1002/ccd.29590. Epub 2021 Mar 2.

Authors

Ellen Vanhie¹, Kristof VandeKerckhove², Nikolaus A Haas³, Daniel De Wolf^{2

4}

Affiliations

¹ Department of Pediatrics, Pediatric Cardiology, Amsterdam University Hospital, Amsterdam, The Netherlands.
² Department of Pediatrics, Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium.
³ Department of Pediatrics, Pediatric Cardiology, LMU Klinikum, München, Germany.
⁴ Department of Pediatrics, Pediatric Cardiology, Brussel University Hospital, Brussels, Belgium.

PMID: 33650782
DOI: 10.1002/ccd.29590

Abstract

This case describes the successful implantation of an Occlutech Atrial Flow Regulator in a young child with idiopathic pulmonary hypertension and recurrent syncope despite targeted combination therapy, with subsequent relief of symptoms.

Keywords: atrial septostomy; cardiac catheterization; syncope.

Publication types

Case Reports

MeSH terms

Cardiac Catheterization
Child
Heart Atria
Humans
Hypertension, Pulmonary* / drug therapy
Lung
Pharmaceutical Preparations*
Treatment Outcome

Substances

Pharmaceutical Preparations